Five North Carolina biotechnology companies have been selected to present their funding needs at Venture '93, the 10th annual venture conference, to be held May 17-18 at Duke University's Fuqua School of Business. ICAgen Inc. of Durham is a start-up biotechnology company seeking seed capital to develop its proprietary techniques for discovery of drugs that modulate ion channels.
Tri-Point Medical of Raleigh is a development-stage company seeking expansion funding to develop and market its bio-adhesives, which provide unique would closure, would management and drug delivery